SYSMEX INOSTICS INC.

In News

Sysmex Inostics Achieves CAP Accreditation and ISO 15189 Certification, Enhancing Quality Standards in Diagnostic Excellence - PR Newswire

PR Newswire - Dec 10, 2024

What MRD in AML Partners Are Saying - FNIH

FNIH - Jun 10, 2023

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Exact Sciences founders raise $56M for new liquid biopsy venture - MedTech Dive

MedTech Dive - Nov 17, 2022

Pap test fluids used in gene-based screening test for two gyn cancers - EurekAlert!

EurekAlert! - Mar 22, 2018

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer - Nature

Nature - Aug 06, 2024

43 Top Biopharma Startups and Companies in Germany - EU-Startups

EU-Startups - Nov 26, 2021

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer | British Journal of Cancer - Nature

Nature - Nov 23, 2018

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples - Nature

Nature - Jun 20, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment